PharmaBoardroom

UK Pharma News Roundup May 2020

Below we highlight some recent developments in pharma and healthcare in the UK, including drug shortages in British intensive care units (ICUs),…

Chae-Ok Yun – Founder, CEO & CTO, GeneMedicine

Founder, CEO and CTO Dr Chae-Ok Yun introduces GeneMedicine, a pioneer of the oncolytic virus approach in gene therapy. Dr Yun outlines the…

Compulsory Licensing & Public Health during the COVID-19…

The COVID-19 pandemic continues to spread rapidly across the globe amid critical supply shortages of medical devices and medicines. The rapid spread…

The UAE: A Gathering Force

Accounting for less than two percent of the global pharmaceutical market, the Middle East has long been somewhat overlooked by many drug makers, most…

Erik Present – President, Healixia, Belgium

Erik Present is president of Healixia, a newly formed association for medical professionals in Belgium. Present introduces the mission and purpose of…

Worried About Biogen’s Aducanumab? Don’t Be

Dr Neil Cashman examines the recent news around Biogen's Alzheimer's treatment aducanumab, assuages some investor fears, and underlines the…

Hot Topics in US Healthcare & Pharma

So far in 2020 PharmaBoardroom has conducted interviews with several key stakeholders in US healthcare. We have heard from leaders the US FDA, as well…

Can the USA’s Fragmented Healthcare System Become More…

US healthcare is often seen as a fragmented system of contrasts. The country has the highest healthcare expenditures as a percentage of GDP and the…

Sabena Solomon – General Manager, GSK Belgium, the…

Sabena Solomon, general manager of GSK Benelux, speaks about her first impressions of the Belgium market, having come from GSK Finland, and her…

Novartis: CAR-T’s Journey to Market in Europe

Two years on from the introduction of Novartis Oncology’s CAR-T therapy to Europe, Emnuele Ostuni, the firm’s European head of cell and gene…

Emanuele Ostuni – Head of Europe, Cell & Gene Therapy,…

Emanuele Ostuni, Novartis Oncology’s head of cell and gene therapy for Europe, gives an overview of the introduction of the company’s CAR-T…

Cell & Gene Therapy Manufacturing: Critical Challenges,…

Deloitte's Omkar Kawalekar, Hussain Mooraj, and Amit Agarwal examine the evolution and future of cell and gene therapy manufacturing and the areas in…

Tagged with HE